Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU SUVEN PHARMACEUTICALS GODAVARI DRU/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x 12.9 134.2 9.6% View Chart
P/BV x 2.2 15.9 13.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GODAVARI DRU   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    GODAVARI DRU
Mar-24
SUVEN PHARMACEUTICALS
Mar-24
GODAVARI DRU/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs114767 14.9%   
Low Rs73375 19.5%   
Sales per share (Unadj.) Rs208.141.3 503.9%  
Earnings per share (Unadj.) Rs7.411.8 62.5%  
Cash flow per share (Unadj.) Rs10.013.9 71.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs51.780.5 64.3%  
Shares outstanding (eoy) m7.53254.57 3.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.513.8 3.3%   
Avg P/E ratio x12.748.4 26.3%  
P/CF ratio (eoy) x9.341.0 22.8%  
Price / Book Value ratio x1.87.1 25.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m705145,357 0.5%   
No. of employees `000NANA-   
Total wages/salary Rs m511,359 3.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,56710,514 14.9%  
Other income Rs m6619 1.0%   
Total revenues Rs m1,57311,133 14.1%   
Gross profit Rs m1324,058 3.3%  
Depreciation Rs m20546 3.7%   
Interest Rs m4975 66.0%   
Profit before tax Rs m694,057 1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m141,054 1.3%   
Profit after tax Rs m553,003 1.8%  
Gross profit margin %8.438.6 21.8%  
Effective tax rate %19.826.0 76.3%   
Net profit margin %3.528.6 12.4%  
BALANCE SHEET DATA
Current assets Rs m88513,623 6.5%   
Current liabilities Rs m8202,061 39.8%   
Net working cap to sales %4.1110.0 3.8%  
Current ratio x1.16.6 16.3%  
Inventory Days Days3318 0.9%  
Debtors Days Days1,384464 298.3%  
Net fixed assets Rs m4639,909 4.7%   
Share capital Rs m75255 29.6%   
"Free" reserves Rs m31420,232 1.6%   
Net worth Rs m39020,487 1.9%   
Long term debt Rs m1120-   
Total assets Rs m1,34823,532 5.7%  
Interest coverage x2.455.4 4.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x1.20.4 260.3%   
Return on assets %7.813.1 59.4%  
Return on equity %14.214.7 97.2%  
Return on capital %23.620.2 117.1%  
Exports to sales %1.50-   
Imports to sales %58.90-   
Exports (fob) Rs m24NA-   
Imports (cif) Rs m923NA-   
Fx inflow Rs m2410,857 0.2%   
Fx outflow Rs m9272,119 43.7%   
Net fx Rs m-9028,737 -10.3%   
CASH FLOW
From Operations Rs m1843,585 5.1%  
From Investments Rs m-132-3,623 3.6%  
From Financial Activity Rs m-57-138 41.0%  
Net Cashflow Rs m-5-176 2.6%  

Share Holding

Indian Promoters % 52.6 0.0 -  
Foreign collaborators % 0.0 50.1 -  
Indian inst/Mut Fund % 0.5 27.7 1.8%  
FIIs % 0.0 10.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.4 49.9 94.9%  
Shareholders   7,709 69,337 11.1%  
Pledged promoter(s) holding % 0.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GODAVARI DRU vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GODAVARI DRU vs SUVEN PHARMACEUTICALS Share Price Performance

Period GODAVARI DRU SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day -1.73% 0.29% 0.51%
1-Month -11.88% 2.23% -0.95%
1-Year 14.70% 109.42% 42.60%
3-Year CAGR 26.40% 37.19% 20.07%
5-Year CAGR 50.60% 50.10% 26.06%

* Compound Annual Growth Rate

Here are more details on the GODAVARI DRU share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of GODAVARI DRU hold a 52.6% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 50.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GODAVARI DRU and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, GODAVARI DRU paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SUVEN PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GODAVARI DRU, and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.